Renal biopsy case: Fibrillary glomerulonephritis associated with hepatitis C viral infection

American Journal of Kidney Diseases

Volumn 29, Issue 1, 1997, Pages 132-135

  Coroneos, Emanuel ^a   Truong, Luan ^a   Olivero, Juan ^a,b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

Fibrillary glomerulonephritis; hepatitis C viral infection; interferon therapy

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; FEMALE; GLOMERULONEPHRITIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY BIOPSY; BIOPSY; KIDNEY; MIDDLE AGED; PATHOLOGY; REMISSION; REVIEW; TIME;

ALPHA INTERFERON;

BIOPSY; FEMALE; GLOMERULONEPHRITIS; HEPATITIS C; HUMANS; INTERFERON-ALPHA; KIDNEY; MIDDLE AGED; REMISSION INDUCTION; TIME FACTORS;

EID: 0030636474     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90020-2     Document Type: Article

References (14)

1. Johnson RJ, Willson R, Yamabe H, Couser W, Alpers C, Wener M, Davis C, Gretch D: Renal manifestations of hepatitis C virus infection. Kidney Int 46:1255-1263, 1994
2. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi C, Hartwell P, Couser W, Covey L, Wener M, Alpers C, Willson R: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328:465-470, 1993
3. Okada K, Takishita Y, Shimomura H, Tsuji T, Miyamura T, Kuhara T, Yasutomo K, Kagami S, Kuroda Y: Detection of hepatitis C virus core protein in the glomeruli of patients with membranous glomerulonephritis. Clin Nephrol 45:71-76, 1996
4. Iskandar SS, Falk RT, Jennette JC: Clinical and pathologic features of fibrillary glomerulonephritis. Kidney Int 42:1401-1407, 1992
5. Yamabe H, Johnson RJ, Gretch DR, Fukushi K, Osawa H, Miyata M, Inuma H, Sasaki T, Kaizuka M, Tamura N, Tsunoda S, Fujita Y, Onodera K: Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol 6:220-223, 1995
6. Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M: Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 117:573-577, 1992
7. Agnello V, Chung RT, Kaplan LM: A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327:1490-1495, 1992
8. Johnson RJ, Gretch DR, Couser WG, Alpers C, Wilson J, Chung M, Hart J, Willson R: Hepatitis C virus-associated glomerulonephritis: Effect of alpha-interferon therapy. Kidney Int 46:1700-1704, 1994
9. Stehmann-Breen C, Alpers CF, Couser WG, Willson R, Johnson RJ: Hepatitis C virus and membranous glomerulonephritis. Clin Nephrol 44:141-147, 1995
10. Alpers CE, Rennke HG, Hopper J Jr, Biava CG: Fibrillary glomerulonephritis: An entity with unusual immunofluorescence features. Kidney Int 31:781-789, 1987
11. Fogo A, Qureshi N, Horn RG: Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy. Am J Kidney Dis 22:367-377, 1993
12. D'Agati V, Sacchi G, Truong L, Venkataseshan S, Kim D, Kim B, Appel G: Fibrillary glomerulopathy (FG): Defining the disease spectrum. J Am Soc Nephrol 2:591, 1991 (abstr)
13. Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi P, Zilio P, Vernocchi A, Massazza M, Vendramin G, Tanzi E, Zanetti P: Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330:751-756, 1994
14. Yamabe H, Johnson R, Gretch D, Osawa H, Inuma H, Sasaki T, Kaizuka M, Tamura N, Tsunoda S, Fujita Y, Sato A, Onodera K: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection responsive to Interferon-a. Am J Kidney Dis 25:67-69, 1995